Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

被引：0
|
作者：
Coles, AJ
Paolillo, A
Molyneux, P
Wing, MG
Hale, G
Miller, D
Waldmann, H
Compston, DAS
机构：
来源：
ANNALS OF NEUROLOGY | 1998年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M92
引用
收藏
页码：464 / 464
页数：1
相关论文
共 50 条
  • [21] Development of anti-CXCL13 monoclonal antibody for the treatment of multiple sclerosis
    Klimatcheva, E.
    Pandina, T.
    Reilly, C.
    Decker, J.
    Jonason, A.
    Scrivens, M.
    Huang, H.
    Cornelius, C.
    Doherty, M.
    Veeraraghavan, J.
    Kirk, R.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Seigel, G.
    Torno, S.
    Richards, T.
    Fisher, T.
    Evans, E.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Bowers, W.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 413 - 413
  • [22] Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody
    Rose, JW
    Watt, HE
    White, AT
    Carlson, NG
    ANNALS OF NEUROLOGY, 2004, 56 (06) : 864 - 867
  • [23] Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis
    Warnke, C.
    Kieseier, B. C.
    Zettl, U.
    Hartung, H-P.
    NERVENARZT, 2009, 80 (04): : 468 - 474
  • [24] From diagnosis to treatment: exploring the mechanisms underlying optic neuritis in multiple sclerosis
    Tong, Bin
    Zhang, Xin
    Hu, Haijian
    Yang, Huayi
    Wang, Xifeng
    Zhong, Maolin
    Yang, Fan
    Hua, Fuzhou
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [25] Mechanisms underlying the immunosuppressive activity of antitransferrin receptor monoclonal antibody
    Li, X
    Cicalese, L
    DeMasi, M
    Benedetti, E
    Rastellini, C
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 136 - 136
  • [26] Monoclonal antibodies in the treatment of multiple sclerosis
    Hartung, Hans-Peter
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 222 (1-2) : 2 - 2
  • [27] Monoclonal Antibodies in the Treatment of Multiple Sclerosis
    Di Pauli, F.
    Berger, T.
    Reindl, M.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (36) : 4858 - 4868
  • [28] Monoclonal antibodies in treatment of multiple sclerosis
    Rommer, P. S.
    Dudesek, A.
    Stueve, O.
    Zettl, U. K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (03): : 373 - 384
  • [29] Monoclonal Antibodies for Multiple Sclerosis Treatment
    Palavra, Filipe
    ACTA MEDICA PORTUGUESA, 2015, 28 (05): : 640 - 651
  • [30] Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis
    Wootla, Bharath
    Watzlawik, Jens O.
    Stavropoulos, Nikolaos
    Wittenberg, Nathan J.
    Dasari, Harika
    Abdelrahim, Murtada A.
    Henley, John R.
    Oh, Sang-Hyun
    Warrington, Arthur E.
    Rodriguez, Moses
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (06) : 827 - 839
12345